QT Imaging (NASDAQ:QTI – Get Free Report) is projected to release its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect QT Imaging to announce earnings of ($0.22) per share and revenue of $7.60 million for the quarter. Interested persons may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Friday, August 7, 2026 at 9:30 AM ET.
QT Imaging (NASDAQ:QTI – Get Free Report) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.11). The company had revenue of $6.53 million during the quarter, compared to analyst estimates of $6.45 million. QT Imaging had a negative return on equity of 4,220.38% and a negative net margin of 58.93%. On average, analysts expect QT Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.
QT Imaging Stock Up 2.3%
QTI opened at $2.71 on Thursday. The company has a quick ratio of 1.69, a current ratio of 2.49 and a debt-to-equity ratio of 1.38. The firm has a market cap of $37.32 million, a P/E ratio of -2.19 and a beta of -0.04. QT Imaging has a 52 week low of $1.44 and a 52 week high of $8.50. The business’s fifty day simple moving average is $3.87 and its 200 day simple moving average is $5.35.
Analysts Set New Price Targets
Get Our Latest Analysis on QTI
QT Imaging Company Profile
QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.
QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.
Read More
- Five stocks we like better than QT Imaging
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
